Ado-trastuzumab emtansine associated spider telangiectasia.
Pınar Gürsoy ÖnerAyda AcarTaner AcikalinPublished in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2022)
We think that T-DM1, which was detected with a low incidence of skin toxicity in studies, may form telangiectatic lesions due to vascular dilatation through emtansine, and therefore care should be taken in the treatment of T-DM1.